Caspofungin versus liposomal amphotericin B for empirical therapy.
Tattevin
Pierre
P
Bareau
Benoît
B
Camus
Christophe
C
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D054714:Echinocandins; D005334:Fever / Q000209:etiology; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D009503:Neutropenia / Q000209:etiology; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin